Compare · SMFR vs WGS
SMFR vs WGS
Side-by-side comparison of Sema4 Holdings Corp. (SMFR) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SMFR and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.61B, about 3.5x SMFR ($744.7M).
- WGS has hit the wire 8 times in the past 4 weeks while SMFR has been quiet.
- WGS has more recent analyst coverage (8 ratings vs 7 for SMFR).
- Company
- Sema4 Holdings Corp.
- GeneDx Holdings Corp.
- Price
- $0.31+26.73%
- $87.40+2.58%
- Market cap
- $744.7M
- $2.61B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 8
- Recent ratings
- 7
- 8
Latest SMFR
- SEC Form SC 13G filed by Sema4 Holdings Corp.
- Saad Kareem sold $625 worth of shares (193 units at $3.24) and converted options into 546 shares, increasing direct ownership by 1% to 24,467 units (SEC Form 4)
- Ryan Jason gifted 73,614 shares, closing all direct ownership in the company (SEC Form 4)
- Sema4 Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Saad Kareem sold $271 worth of shares (105 units at $2.58), decreasing direct ownership by 0.43% to 24,114 units (SEC Form 4)
- Saad Kareem converted options into 273 shares, increasing direct ownership by 1% to 24,219 units (SEC Form 4)
- Ryan Jason converted options into 67,780 shares, increasing direct ownership by 1,162% to 73,614 units (SEC Form 4)
- Stueland Katherine converted options into 18,750 shares and sold $25,338 worth of shares (11,734 units at $2.16), increasing direct ownership by 15% to 52,578 units (SEC Form 4)
- Saad Kareem converted options into 5,114 shares and sold $3,671 worth of shares (1,700 units at $2.16), increasing direct ownership by 17% to 23,946 units (SEC Form 4)
- Feeley Kevin converted options into 7,197 shares and sold $6,366 worth of shares (2,948 units at $2.16), increasing direct ownership by 23% to 23,035 units (SEC Form 4)
Latest WGS
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026